HBPCF (Helix BioPharma) Buyback Yield %: -1.38 (As of Jun. 29, 2026)


HBPCF Helix BioPharma Corp HBPCF
28 GF Score
Price $1.71
View Full Analysis

What is Helix BioPharma Buyback Yield %?

Helix BioPharma HBPCF 28 Buyback Yield % is -1.38 as of Jun. 29, 2026. GuruFocus rates HBPCF with a GF Score™ of 28/100. Among 742 Biotechnology companies, Helix BioPharma ranks better than 71.16% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Helix BioPharma's current buyback yield was -1.38%.

Helix BioPharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Helix BioPharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helix BioPharma Buyback Yield % Chart

Helix BioPharma Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.81 -8.70 -10.00 -9.86 -4.41

Helix BioPharma Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.63 -3.38 -2.84 -1.05 -1.01

HBPCF vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Helix BioPharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helix BioPharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's Buyback Yield % falls into.


HBPCF
28GF Score
Helix BioPharma Corp HBPCF
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Helix BioPharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Helix BioPharma's Buyback Yield for the fiscal year that ended in Jul. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 1.961) / 44.4936
=-4.41%

Helix BioPharma's annualized Buyback Yield for the quarter that ended in Apr. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 1.092) / 132.13394
=-0.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -1.38 mean?
Helix BioPharma (HBPCF) has a Buyback Yield % of -1.38 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Helix BioPharma and its competitors. According to the industry distribution chart, Helix BioPharma ranks #214 out of 742 companies in the Biotechnology industry, placing it in the top 28.8%.
Is Helix BioPharma's Buyback Yield % too high?
Helix BioPharma's current Buyback Yield % is -1.38. Based on the distribution chart, Helix BioPharma ranks #214 out of 742 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Helix BioPharma has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Helix BioPharma's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Helix BioPharma ranks #214 out of 742 companies for Buyback Yield %. This puts Helix BioPharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Helix BioPharma and its competitors. Helix BioPharma's current Buyback Yield % is -1.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helix BioPharma stock overvalued right now?
Helix BioPharma (HBPCF) has a current Buyback Yield % of -1.38. The current Buyback Yield % is -1.38. Helix BioPharma's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Helix BioPharma (HBPCF), the current Buyback Yield % is -1.38 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Helix BioPharma Business Description

Other Exchanges HBP0:GermanyHBP:Canada
Address 40 Temperance Street, Suite 2700, Bay Adelaide Centre - North Tower, Toronto, ON, CAN, M5H0B4
Helix BioPharma Corp is a clinical-stage biopharmaceutical company developing therapies in immune-oncology focused on cancer prevention and treatment. The Company is developing a proprietary platform of bio-conjugates targeting hard-to-treat solid tumors over-expressing CEACAM6, including Tumor Defense Breaker, L-DOS47, and three CEACAM6-specific antibody-drug conjugates. Its pre-IND candidates include LEUMUNA, an oral immune checkpoint modulator for hematological malignancies, and GEMCEDA, an oral prodrug of gemcitabine for solid tumors.
28GF Score

Get the complete analysis for HBPCF

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.71
Price